Literature DB >> 24134593

Characteristics of the pediatric patients treated by the Pediatric Emergency Care Applied Research Network's affiliated EMS agencies.

E Brooke Lerner1, Peter S Dayan, Kathleen Brown, Susan Fuchs, Julie Leonard, Dominic Borgialli, Lynn Babcock, John D Hoyle, Maria Kwok, Kathleen Lillis, Lise E Nigrovic, Prashant Mahajan, Alexander Rogers, Hamilton Schwartz, Joyce Soprano, Nicholas Tsarouhas, Samuel Turnipseed, Tomohiko Funai, George Foltin.   

Abstract

OBJECTIVE: To describe pediatric patients transported by the Pediatric Emergency Care Applied Research Network's (PECARN's) affiliated emergency medical service (EMS) agencies and the process of submitting and aggregating data from diverse agencies.
METHODS: We conducted a retrospective analysis of electronic patient care data from PECARN's partner EMS agencies. Data were collected on all EMS runs for patients less than 19 years old treated between 2004 and 2006. We conducted analyses only for variables with usable data submitted by a majority of participating agencies. The investigators aggregated data between study sites by recoding it into categories and then summarized it using descriptive statistics.
RESULTS: Sixteen EMS agencies agreed to participate. Fourteen agencies (88%) across 11 states were able to submit patient data. Two of these agencies were helicopter agencies (HEMS). Mean time to data submission was 378 days (SD 175). For the 12 ground EMS agencies that submitted data, there were 514,880 transports, with a mean patient age of 9.6 years (SD 6.4); 53% were male, and 48% were treated by advanced life support (ALS) providers. Twenty-two variables were aggregated and analyzed, but not all agencies were able to submit all analyzed variables and for most variables there were missing data. Based on the available data, median response time was 6 minutes (IQR: 4-9), scene time 15 minutes (IQR: 11-21), and transport time 9 minutes (IQR: 6-13). The most common chief complaints were traumatic injury (28%), general illness (10%), and respiratory distress (9%). Vascular access was obtained for 14% of patients, 3% received asthma medication, <1% pain medication, <1% assisted ventilation, <1% seizure medication, <1% an advanced airway, and <1% CPR. Respiratory rate, pulse, systolic blood pressure, and GCS were categorized by age and the majority of children were in the normal range except for systolic blood pressure in those under one year old.
CONCLUSIONS: Despite advances in data definitions and increased use of electronic databases nationally, data aggregation across EMS agencies was challenging, in part due to variable data collection methods and missing data. In our sample, only a small proportion of pediatric EMS patients required prehospital medications or interventions.

Entities:  

Mesh:

Year:  2013        PMID: 24134593     DOI: 10.3109/10903127.2013.836262

Source DB:  PubMed          Journal:  Prehosp Emerg Care        ISSN: 1090-3127            Impact factor:   3.077


  18 in total

1.  Emergency Medical Services Administration of Systemic Corticosteroids for Pediatric Asthma: A Statewide Study of Emergency Department Outcomes.

Authors:  Jennifer N Fishe; Shiva Gautam; Phyllis Hendry; Kathryn V Blake; Leslie Hendeles
Journal:  Acad Emerg Med       Date:  2019-02-01       Impact factor: 3.451

2.  A Statewide Study of the Epidemiology of Emergency Medical Services' Management of Pediatric Asthma.

Authors:  Jennifer N Fishe; Eugene Palmer; Erik Finlay; Carmen Smotherman; Shiva Gautam; Phyllis Hendry; Leslie Hendeles
Journal:  Pediatr Emerg Care       Date:  2019-02-14       Impact factor: 1.454

3.  A Geospatial Analysis of Distances to Hospitals that Admit Pediatric Asthma Patients.

Authors:  Jennifer Fishe; Erik Finlay; Sam Palmer; Phyllis Hendry
Journal:  Prehosp Emerg Care       Date:  2019-04-05       Impact factor: 3.077

4.  Clinical, Operational, and Socioeconomic Analysis of EMS Bypass of the Closest Facility for Pediatric Asthma Patients.

Authors:  Erik Finlay; Sam Palmer; Benjamin Abes; Benjamin Abo; Jennifer N Fishe
Journal:  West J Emerg Med       Date:  2021-07-15

5.  National Characteristics of Non-Transported Children by Emergency Medical Services in the United States.

Authors:  Caleb Ward; Anqing Zhang; Kathleen Brown; Joelle Simpson; James Chamberlain
Journal:  Prehosp Emerg Care       Date:  2021-11-03       Impact factor: 2.686

6.  Early administration of steroids in the ambulance setting: Protocol for a type I hybrid effectiveness-implementation trial with a stepped wedge design.

Authors:  Jennifer N Fishe; Phyllis Hendry; Jennifer Brailsford; Ramzi G Salloum; Bruce Vogel; Erik Finlay; Sam Palmer; Susmita Datta; Leslie Hendeles; Kathryn Blake
Journal:  Contemp Clin Trials       Date:  2020-09-12       Impact factor: 2.226

7.  Pediatric Airway Management and Prehospital Patient Safety: Results of a National Delphi Survey by the Children's Safety Initiative-Emergency Medical Services for Children.

Authors:  Matthew Hansen; Garth Meckler; Kerth OʼBrien; Phillip Engle; Caitlin Dickinson; Kathryn Dickinson; Jonathan Jui; William Lambert; Erika Cottrell; Jeanne-Marie Guise
Journal:  Pediatr Emerg Care       Date:  2016-09       Impact factor: 1.454

8.  Out-of-Hospital Pediatric Patient Safety Events: Results of the CSI Chart Review.

Authors:  Garth Meckler; Matthew Hansen; William Lambert; Kerth O'Brien; Caitlin Dickinson; Kathryn Dickinson; Joshua Van Otterloo; Jeanne-Marie Guise
Journal:  Prehosp Emerg Care       Date:  2017-10-12       Impact factor: 3.077

9.  Comparison of Errors Using Two Length-Based Tape Systems for Prehospital Care in Children.

Authors:  Lara D Rappaport; Lina Brou; Tim Givens; Maria Mandt; Ashley Balakas; Kelley Roswell; Jason Kotas; Kathleen M Adelgais
Journal:  Prehosp Emerg Care       Date:  2016-02-02       Impact factor: 3.077

10.  Impact of prehospital pediatric asthma management protocol adherence on clinical outcomes.

Authors:  Alexandra L Cheetham; Nidhya Navanandan; Jan Leonard; Kelsey Spaur; Geoffrey Markowitz; Kathleen M Adelgais
Journal:  J Asthma       Date:  2021-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.